ArticleCardiovascular research2025

Tirzepatide alleviates doxorubicin-induced cardiotoxicity via inhibiting HRD1-mediated Nrf2 ubiquitination.

Dan Yang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.